149 related articles for article (PubMed ID: 33329930)
1. Quantitative parameters of MRI and
Gelezhe PB; Blokhin IA; Marapov DI; Morozov SP
Am J Nucl Med Mol Imaging; 2020; 10(6):279-292. PubMed ID: 33329930
[TBL] [Abstract][Full Text] [Related]
2. Diffusion-weighted imaging and (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer: Correlation of the apparent diffusion coefficient and maximum standardized uptake values with prognostic factors.
Karan B; Pourbagher A; Torun N
J Magn Reson Imaging; 2016 Jun; 43(6):1434-44. PubMed ID: 26663655
[TBL] [Abstract][Full Text] [Related]
3. Correlation of the SUVmax of FDG-PET and ADC values of diffusion-weighted MR imaging with pathologic prognostic factors in breast carcinoma.
Kitajima K; Yamano T; Fukushima K; Miyoshi Y; Hirota S; Kawanaka Y; Miya M; Doi H; Yamakado K; Hirota S
Eur J Radiol; 2016 May; 85(5):943-9. PubMed ID: 27130054
[TBL] [Abstract][Full Text] [Related]
4. Percentage change of primary tumor on 18F-FDG PET/CT as a prognostic factor for invasive ductal breast cancer with axillary lymph node metastasis: Comparison with MRI.
Yoo J; Kim BS; Chung J; Yoon HJ
Medicine (Baltimore); 2017 Aug; 96(31):e7657. PubMed ID: 28767583
[TBL] [Abstract][Full Text] [Related]
5. A new method for apparent diffusion coefficient measurement using sequential (18)F-FDG PET and MRI: correlation with histological grade of invasive ductal carcinoma of the breast.
Byun BH; Noh WC; Lim I; Lee SS; Cho AR; Park JA; Kim KM; Kim HA; Kim EK; Kim BI; Choi CW; Lim SM
Ann Nucl Med; 2013 Oct; 27(8):720-8. PubMed ID: 23700260
[TBL] [Abstract][Full Text] [Related]
6. FDG PET/CT and diffusion-weighted imaging for breast cancer: prognostic value of maximum standardized uptake values and apparent diffusion coefficient values of the primary lesion.
Nakajo M; Kajiya Y; Kaneko T; Kaneko Y; Takasaki T; Tani A; Ueno M; Koriyama C; Nakajo M
Eur J Nucl Med Mol Imaging; 2010 Nov; 37(11):2011-20. PubMed ID: 20607535
[TBL] [Abstract][Full Text] [Related]
7. Correlation of Prognostic Factors of Invasive Lobular Carcinoma with ADC Value of DWI and SUVMax of FDG-PET.
Choi BB; Kim SH; Park CS; Jung NY
Chonnam Med J; 2017 May; 53(2):133-139. PubMed ID: 28584792
[TBL] [Abstract][Full Text] [Related]
8. Correlations between DW-MRI and
Connor S; Sit C; Anjari M; Szyszko T; Dunn J; Pai I; Cook G; Goh V
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1360. PubMed ID: 33960739
[TBL] [Abstract][Full Text] [Related]
9. Comparison between
Ozen A; Sayin T; Kandemir O; Ekmekcioglu O; Altınay S; Bastug E; Muhammedoglu A; Celik A; Albayrak R
Asia Ocean J Nucl Med Biol; 2024; 12(1):11-20. PubMed ID: 38164229
[TBL] [Abstract][Full Text] [Related]
10. Integrated PET/MR mammography for quantitative analysis and correlation to prognostic factors of invasive ductal carcinoma.
Kong E; Chun KA; Bae YK; Cho IH
Q J Nucl Med Mol Imaging; 2018 Mar; 62(1):118-126. PubMed ID: 26784940
[TBL] [Abstract][Full Text] [Related]
11. FDG-PET/CT and diffusion-weighted imaging for resected lung cancer: correlation of maximum standardized uptake value and apparent diffusion coefficient value with prognostic factors.
Usuda K; Funasaki A; Sekimura A; Motono N; Matoba M; Doai M; Yamada S; Ueda Y; Uramoto H
Med Oncol; 2018 Apr; 35(5):66. PubMed ID: 29633024
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted imaging and FDG PET/CT: predicting the prognoses with apparent diffusion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma.
Choi BB; Kim SH; Kang BJ; Lee JH; Song BJ; Jeong SH; Yim HW
World J Surg Oncol; 2012 Jun; 10():126. PubMed ID: 22741544
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric functional MRI and
Martens RM; Koopman T; Lavini C; Ali M; Peeters CFW; Noij DP; Zwezerijnen G; Marcus JT; Vergeer MR; Leemans CR; de Bree R; de Graaf P; Boellaard R; Castelijns JA
Eur Radiol; 2021 Feb; 31(2):616-628. PubMed ID: 32851444
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic value of pretreatment SUV in 18F-FDG/PET in breast cancer: comparison with apparent diffusion coefficient from diffusion-weighted MR imaging.
Baba S; Isoda T; Maruoka Y; Kitamura Y; Sasaki M; Yoshida T; Honda H
J Nucl Med; 2014 May; 55(5):736-42. PubMed ID: 24665089
[TBL] [Abstract][Full Text] [Related]
15. Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancer.
Goense L; Heethuis SE; van Rossum PSN; Voncken FEM; Lagendijk JJW; Lam MGEH; Terhaard CH; van Hillegersberg R; Ruurda JP; Mook S; van Lier ALHMW; Lin SH; Meijer GJ
Nucl Med Commun; 2018 Jan; 39(1):60-67. PubMed ID: 29023336
[TBL] [Abstract][Full Text] [Related]
16. Application of Simultaneous
Huang Z; Li X; Wang Z; Meng N; Fu F; Han H; Li D; Bai Y; Wei W; Fang T; Feng P; Yuan J; Yang Y; Wang M
J Magn Reson Imaging; 2022 Jul; 56(1):63-74. PubMed ID: 34888990
[TBL] [Abstract][Full Text] [Related]
17. The correlation of
Qu YH; Long N; Ran C; Sun J
Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
[TBL] [Abstract][Full Text] [Related]
18. Variability of target and normal structure delineation using multimodality imaging for radiation therapy of pancreatic cancer.
Dalah E; Moraru I; Paulson E; Erickson B; Li XA
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):633-40. PubMed ID: 24755533
[TBL] [Abstract][Full Text] [Related]
19. Prediction of tumor differentiation using sequential PET/CT and MRI in patients with breast cancer.
Choi JH; Lim I; Noh WC; Kim HA; Seong MK; Jang S; Seol H; Moon H; Byun BH; Kim BI; Choi CW; Lim SM
Ann Nucl Med; 2018 Jul; 32(6):389-397. PubMed ID: 29797002
[TBL] [Abstract][Full Text] [Related]
20. ¹⁸F-FDG PET/CT imaging versus dynamic contrast-enhanced CT for staging and prognosis of inflammatory breast cancer.
Champion L; Lerebours F; Cherel P; Edeline V; Giraudet AL; Wartski M; Bellet D; Alberini JL
Eur J Nucl Med Mol Imaging; 2013 Aug; 40(8):1206-13. PubMed ID: 23640467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
